Skip to content

kTMP in Chronic Stroke

KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07277595
Acronym
KULMINATE
Enrollment
100
Registered
2025-12-11
Start date
2026-07-01
Completion date
2030-08-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arm Weakness as a Consequence of Stroke, Chronic Stroke Patients, Stroke

Keywords

transcranial magnetic stimulation

Brief summary

kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.

Interventions

DEVICEkTMP sham stimulation 9 weeks + active stimulation 9 weeks

kTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation

DEVICEkTMP 18 weeks

Participants receive kTMP active stimulation for 18 weeks

Sponsors

University of California, San Francisco
Lead SponsorOTHER
National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adults age 18-80 years old who have had a stroke resulting in hemiplegia * Ability to communicate, understand, and give appropriate consent * Other criteria may apply

Exclusion criteria

* Significant cognitive impairment * inability to adhere to the study protocol or provide informed consent * pregnancy * additional criteria may apply

Design outcomes

Primary

MeasureTime frameDescription
Fugl Meyer AssessmentEnrollment, then weeks 3, 6, 9, 12, 15, 18, and 34.The Fugl-Meyer Assessment (FMA) is a structured evaluation used to measure motor recovery after a stroke, with a total score range of 0-226. Higher scores indicate better motor function, while lower scores reflect greater impairment.

Secondary

MeasureTime frameDescription
Wolf Motor Function TestAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34Measures timed functional tasks, strength testing, and analysis of movement quality when completing various upper extremity tasks. Uses a 6 point ordinal scale (0-5), where ) is does not attempt with the involved arm and 5 is arm does participate and movement appears normal. Maximum score of 75. Lower scores indicate lower functional levels.
Stroke Impact ScaleAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34Self reported questionnaire that evaluates disability and health related quality of life after stroke, consisting of 59 items, assessing strength, hand function, ADL/iADL, mobility, communication, emotion, memory and thinking, participation/role function. Each item is rated in a 5 point Likert scale, where 1 equals could not do it at all and 5 equals not difficult at all. Score ranges 0-100. Higher score indicates less disability and high quality of life after stroke.
Stroke Specific QOLAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34Questionnaire consisting of 49 items in the 12 domains of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking and personality. Each item is assessed on a 5 point Guttman type scale, where 1=total help; couldn't do it at all; strongly agree and 5 =no help needed; no trouble at all; strongly disagree. Higher scores indicate better functioning.
EuroQOLAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34A health questionnaire that measures 5 dimensions including mobility, self-care, usual activities, pain/discomfort, anxiety/depression. Each item is described by 3 levels of problems, where 1=none, 2=mild to moderate, and 3=severe. This provides a simple single index value for health status, where a higher score indicates worse health state.
Motor Activity LogAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34Self reported perception of Quality of movement are rated in 30 functional tasks, scored on a 6 point ordinal scale where 0=weaker arm not used at all for that activity and 5=ability to use the weaker arm for that activity is as good as before the stroke(normal). A higher score indicates better quality upper extremity movement.
Modified Ashworth Scale ScoresAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34Test of resistance to passive movement about a joint, scores range from 0 to 5 where 0=no increase in muscle tone and 5=affected part(s) rigid. Hight scores indicate greater muscle tone.
Action Research Arm TestAt enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34Measures performance of the upper extremity in grasp, grip, pinch, and gross arm movements, rated on a 4 point ordinal scale where 3=performs test normally and 0=can perform no part of test. Higher score indicates greater function of the upper extremity.

Countries

United States

Contacts

CONTACTKarunesh Ganguly, MD, PhD
karunesh.ganguly@ucsf.edu415-514-1252
PRINCIPAL_INVESTIGATORKarunesh Ganguly, MD, PhD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026